Back
Nektar Therapeutics Stock Price Chart
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$0.88
Seasonality Move:
0.09%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and NKTR is experiencing slight selling pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.86 | Buy |
| 20-day SMA: | 0.88 | Buy |
| 50-day SMA: | 0.89 | Buy |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 0.86 | Buy |
| 20-day EMA: | 0.86 | Buy |
| 50-day EMA: | 0.9 | Buy |
| 200-day EMA: | 1.06 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 55.63 | Buy |
| Chaikin Money Flow: | -631563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.94) | Buy |
| Bollinger Bands (100): | (0.82 - 1.22) | Sell |
Nektar Therapeutics Technical Analysis
| Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.91 while NKTR 8-day simple moving average is 0.86, which is a Buy signal.
-
The stock price of NKTR is 0.91 while Nektar Therapeutics 20-day SMA is 0.88, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 0.89 while NKTR share price is 0.91, making it a Buy technically.
-
NKTR stock price is 0.91 and Nektar Therapeutics 200-day simple moving average is 1.15, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.91. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
167.7M
Price in USD:
0.91
Share Volume:
2.1M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.65
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.91 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.91 while NKTR 8-day exponential moving average is 0.86, which is a Buy signal.
-
The stock price of NKTR is 0.91 while Nektar Therapeutics 20-day EMA is 0.86, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 0.90 while NKTR share price is 0.91, making it a Buy technically.
-
NKTR stock price is 0.91 and Nektar Therapeutics 200-day simple moving average is 1.06, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 55.63, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.74 - 0.94), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.82 - 1.22), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.